Alterations in signaling pathway activity have been implicated in the pathogenesis of Duchenne muscular dystrophy, a degenerative muscle disease caused by a deficiency in the costameric protein dystrophin. Accordingly, the notion of the dystrophin-glycoprotein complex, and by extension the costamere, as harboring signaling components has received increased attention in recent years. The localization of most, if not all, signaling enzymes to this subcellular region relies on interactions with scaffolding proteins directly or indirectly associated with the dystrophin-glycoprotein complex. One of these scaffolds is myospryn, a large, muscle-specific protein kinase A (PKA) anchoring protein or AKAP. Previous studies have demonstrated a dysregulation of myospryn expression in human Duchenne muscular dystrophy, suggesting a connection to the pathophysiology of the disorder. Here we report that dystrophic muscle exhibits reduced PKA activity resulting, in part, from severely mislocalized myospryn and the type II regulatory subunit (RII␣) of PKA. Furthermore, we show that myospryn and dystrophin coimmunoprecipitate in native muscle extracts and directly interact in vitro. Our findings reveal for the first time abnormalities in the PKA signal transduction pathway and myospryn regulation in dystrophin deficiency.The major macromolecular protein complex within the muscle costamere is the dystrophin-glycoprotein complex (DGC).
2The DGC harbors the large, actin-binding protein dystrophin, the absence of which results in Duchenne muscular dystrophy (DMD), a lethal, X-linked degenerative muscle disease (1-4). It is undisputed that defects within the DGC are one of the major triggers of muscular dystrophy, yet the mechanisms by which a defective DGC leads to muscle degeneration remain unclear. Hence, intense efforts have been put forth to molecularly dissect the function of dystrophin as well as the DGC (5, 6) and to identify novel regulators of this complex in striated muscle.Dystrophin serves as a scaffold for numerous protein-protein interactions with components of the DGC as well as non-DGC proteins at the level of the costamere (7, 8). The prevailing model suggests a structural and mechanical role for dystrophin (9), but an additional function in signaling has been proposed (10, 11). Although elucidating the role of dystrophin in signaling has been a challenging task, there is evidence of altered signaling activity in muscular dystrophies. Alterations in calcium levels and the neuronal nitric oxide synthase pathway in DMD have been known for some time (12)(13)(14). Perturbations in the activity of additional signaling molecules such as calcineurin, Akt, JNK1, and IB kinase/ NF-B have been linked to muscular dystrophies (15)(16)(17)(18)(19).Recently, we showed that the costameric protein myospryn functions as a muscle-specific protein kinase A (PKA) anchoring protein or AKAP (20). This was the first demonstration of myospryn coordinating the PKA signaling pathway at the level of the costamere. The AKAP family of scaffolding...